IL105541A - Monoclonal antibodies to PG 031 protein, processes for their preparation and pharmaceutical preparations containing them - Google Patents

Monoclonal antibodies to PG 031 protein, processes for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL105541A
IL105541A IL105541A IL10554193A IL105541A IL 105541 A IL105541 A IL 105541A IL 105541 A IL105541 A IL 105541A IL 10554193 A IL10554193 A IL 10554193A IL 105541 A IL105541 A IL 105541A
Authority
IL
Israel
Prior art keywords
monoclonal antibody
protein
hybridoma
gpx
antibody
Prior art date
Application number
IL105541A
Other languages
English (en)
Hebrew (he)
Other versions
IL105541A0 (en
Original Assignee
Tosoh Corp Yamaguchi And Tadam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosoh Corp Yamaguchi And Tadam filed Critical Tosoh Corp Yamaguchi And Tadam
Publication of IL105541A0 publication Critical patent/IL105541A0/xx
Publication of IL105541A publication Critical patent/IL105541A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL105541A 1992-04-28 1993-04-28 Monoclonal antibodies to PG 031 protein, processes for their preparation and pharmaceutical preparations containing them IL105541A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4134329A JPH05304986A (ja) 1992-04-28 1992-04-28 ｇｐ１３０蛋白質に対するモノクロ−ナル抗体

Publications (2)

Publication Number Publication Date
IL105541A0 IL105541A0 (en) 1993-08-18
IL105541A true IL105541A (en) 1998-06-15

Family

ID=15125789

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105541A IL105541A (en) 1992-04-28 1993-04-28 Monoclonal antibodies to PG 031 protein, processes for their preparation and pharmaceutical preparations containing them

Country Status (5)

Country Link
US (1) US5866689A (ja)
EP (1) EP0572118B1 (ja)
JP (1) JPH05304986A (ja)
DE (1) DE69319662T2 (ja)
IL (1) IL105541A (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017121B2 (en) 1994-06-30 2011-09-13 Chugai Seiyaku Kabushika Kaisha Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
PT783893E (pt) * 1994-10-07 2012-05-24 Chugai Pharmaceutical Co Ltd Inibição do crescimento anormal das células sinoviais usando antagonistas de il-6 como componente ativo
FR2733250B1 (fr) * 1995-04-21 1997-07-04 Diaclone Anticorps monoclonaux anti-gp130, et leurs utilisations
US5571513A (en) * 1995-05-31 1996-11-05 The Board Of Regents Of The University Of Oklahoma Anti-gp130 monoclonal antibodies
US6217858B1 (en) 1997-02-11 2001-04-17 Hadasit & Medical Research Services & Development Company, Ltd. Pharmaceutical composition for treating hepatitis B virus (HBV) infection
JPH10324639A (ja) * 1997-03-21 1998-12-08 Chugai Pharmaceut Co Ltd Ｉｌ−６アンタゴニストを有効成分として含有する感作ｔ細胞関与疾患の予防・治療剤
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
AU757261B2 (en) 1998-08-24 2003-02-13 Chugai Seiyaku Kabushiki Kaisha Preventives or remedies for pancreatitis containing IL-6 antagonists as the active ingredient
US6980958B1 (en) * 2000-01-11 2005-12-27 Zycare, Inc. Apparatus and methods for monitoring and modifying anticoagulation therapy of remotely located patients
JP2005516001A (ja) 2001-12-05 2005-06-02 ベイラー カレッジ オブ メディスン 交感神経活動状態の調節による骨形成の制御のための方法及び組成物
PE20061324A1 (es) 2005-04-29 2007-01-15 Centocor Inc Anticuerpos anti-il-6, composiciones, metodos y usos
CA2666599A1 (en) 2006-08-18 2008-02-21 Ablynx N.V. Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
WO2008036973A2 (en) 2006-09-22 2008-03-27 St. Jude Children's Research Hospital Modulating regulatory t cell activity via interleukin 35
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
MX2009012492A (es) 2007-05-21 2010-01-20 Alder Biopharmaceuticals Inc Anticuerpos para il-6 y sus usos.
US20090238825A1 (en) * 2007-05-21 2009-09-24 Kovacevich Brian R Novel rabbit antibody humanization methods and humanized rabbit antibodies
US8178101B2 (en) * 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US7906117B2 (en) * 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
TWI609965B (zh) * 2007-05-21 2018-01-01 艾爾德生物控股有限責任公司 新穎兔抗體人化方法以及經人化之兔抗體
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses
US9452227B2 (en) * 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
ES2363358B1 (es) * 2009-04-03 2012-06-21 FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON (Titular al Agentes terapéuticos para el tratamiento de enfermedades asociadas con una proliferación celular indeseable.
RU2539798C2 (ru) 2009-04-10 2015-01-27 Аблинкс Нв Улучшенные аминокислотные последовательности против il-6r и содержащие их полипептиды для лечения связанных с il-6r заболеваний и нарушений
WO2010115995A2 (en) 2009-04-10 2010-10-14 Ablynx Nv Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
WO2011063198A2 (en) 2009-11-20 2011-05-26 St. Jude Children's Research Hospital Methods and compositions for modulating the activity of the interleukin-35 receptor complex
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
WO2011066374A2 (en) 2009-11-24 2011-06-03 Alder Biopharmaceuticals, Inc. Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
EP2371860A1 (en) 2010-04-05 2011-10-05 Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
JPWO2012067150A1 (ja) * 2010-11-16 2014-05-12 三菱化学株式会社 Ｉｎｔｅｒｌｅｕｋｉｎ−６ｒｅｃｅｐｔｏｒｓｕｂｕｎｉｔｂｅｔａ蛋白質による脳梗塞の検査方法
EP2643016A2 (en) 2010-11-23 2013-10-02 Alder Biopharmaceuticals, Inc. Anti-il-6 antibodies for the treatment of anemia
WO2013041722A1 (en) 2011-09-23 2013-03-28 Ablynx Nv Prolonged inhibition of interleukin-6 mediated signaling
WO2016062766A1 (en) 2014-10-21 2016-04-28 Ablynx Nv Treatment of il-6r related diseases
JP7206772B2 (ja) * 2018-02-27 2023-01-18 東ソー株式会社 ヒトｇｐ１３０受容体に対するヒト化抗体
US11897951B2 (en) 2020-12-18 2024-02-13 Ablynx N.V. Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2898064B2 (ja) * 1989-08-03 1999-05-31 忠三 岸本 ヒトｇｐ１３０蛋白質

Also Published As

Publication number Publication date
EP0572118A1 (en) 1993-12-01
DE69319662D1 (de) 1998-08-20
DE69319662T2 (de) 1998-12-10
US5866689A (en) 1999-02-02
JPH05304986A (ja) 1993-11-19
EP0572118B1 (en) 1998-07-15
IL105541A0 (en) 1993-08-18

Similar Documents

Publication Publication Date Title
EP0572118B1 (en) Monoclonal antibodies to GP130 protein
EP0811065B1 (en) Antagonists of interleukin-15
US5670373A (en) Antibody to human interleukin-6 receptor
JP4764627B2 (ja) 新生物疾患又は免疫不全を処置するためのヒト化免疫調節性モノクローナル抗体
FI91421C (fi) Menetelmä ihmisen kasvainkuoliotekijän (TNF) kanssa reagoivan monoklonaalisen vasta-aineen valmistamiseksi ja vasta-ainetta tuottava hybridisolulinja
US5470571A (en) Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
EP0409607B1 (en) Antibody to human interleukin-6 receptor
US9163084B2 (en) Antibodies which bind human CXCR3
CA2165573A1 (en) Anti-.alpha.v-integrin monoclonal antibody
HU218100B (hu) Limfocita antigén CD2-t és tumor antigéneket felismerő bispecifikus triggermolekulák
JP2002501085A5 (ja)
WO1995009873A1 (en) A monoclonal anti-human il-6 receptor antibody
US5747032A (en) Monoclonal antibody to human granulocyte macrophage colony stimulating factor
EP0504307B1 (en) Method of treating septic shock
CA1340437C (en) Interleukin 2 receptor and applications thereof
Takatsu Interleukin 5 (IL-5) and its receptor
Stracke et al. Binding properties and histamine release in variants of rat basophilic leukemia cells with changes in the IgE receptor
Toshiro et al. Analysis of interleukin 6 (IL-6)/IL-6 receptor system using monoclonal anti-IL-6 antibodies
US5833983A (en) Interleukin 2 receptor and applications thereof
LIU et al. Generation of murine monoclonal antibodies in serum-free medium
JP3447322B2 (ja) マウス細胞表面抗原に対するハムスターモノクローナル抗体
AU673858B2 (en) Monoclonal antibody
Sun et al. Antitumour activity of a chimeric antibody against the leucocyte antigen CD48
EP0322254B1 (en) Monoclonal antibody capable of suppressing T lymphocyte proliferation
CA1340761C (en) Interleukin-4-receptors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired